Filing Details
- Accession Number:
- 0001415889-23-016539
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-15 18:00:07
- Reporting Period:
- 2023-12-13
- Accepted Time:
- 2023-12-15 18:00:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1798749 | Aerovate Therapeutics Inc. | AVTE | Pharmaceutical Preparations (2834) | 831377888 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1868997 | Hunter Gillies | C/O Aerovate Therapeutics, Inc. 930 Winter Street, Suite M-500 Waltham MA 02451 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-13 | 2,103 | $1.74 | 5,354 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-13 | 2,103 | $19.50 | 3,251 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-12-14 | 9,897 | $1.74 | 13,148 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-14 | 9,897 | $19.50 | 3,251 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-13 | 653 | $0.00 | 653 | $1.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-13 | 1,450 | $0.00 | 1,450 | $1.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-14 | 2,700 | $0.00 | 2,700 | $1.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-14 | 7,197 | $0.00 | 7,197 | $1.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,444 | 2030-09-03 | No | 4 | M | Direct | |
| 17,503 | 2030-09-03 | No | 4 | M | Direct | |
| 12,744 | 2030-09-03 | No | 4 | M | Direct | |
| 10,306 | 2030-09-03 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023.
- A total of 16,097 shares subject to an employee stock option were granted on September 4, 2020, with 10% of this option vested on May 1, 2020, 22.5% vested on May 1 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
- A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
Billionaire Hedge Funds
